THE AUTEM THERAPEUTICS TEAM

We are data-driven, patient-focused game changers with a mission to improve the way we fight cancer.

Michael Choukas
Co-founder and Chief Executive Officer (CEO)
USA

Experienced Chief Executive with global strategy, operations, clinical development, clinical trials and real-world data (RWD) analytics experience at ConcertAI, Vector Oncology, UBC, SCIREX and Bain & Company. B.A. Dartmouth; M.B.A. Harvard.
Frederico Costa, MD
Founder and Chief Scientific Officer (CSO)
Brazil

Medical oncologist, co-founder and on the faculty of the Centro de Oncologia of Hospital Sírio Libanês. He is a former Medical Oncology/Hematology Fellow at Memorial Sloan-Kettering Cancer Center in New York, USA.

Bertram Wiedenmann, MD PhD
Chief Medical Officer (CMO)
Germany

Professor, Department of Internal Medicine, Division of Hepatology and Gastroenterology, Charité, University of Berlin. Chair, American Society of Clinical Oncology (ASCO) GI Cancer Symposium 2017, San Francisco, CA.


Edward Stepanski, PhD
VP, Clinical Development
USA

Managed operations in an oncology clinical trials network, and built an oncology-focused full service CRO directing all aspects of trial activity for over 10 years. Most recently built real world datasets in oncology for regulatory submissions and other life sciences use cases for a major RWD company.
Andrew Powell
VP, Business Development and Legal Affairs
USA

Executive with track record generating global value through IP creation, M&A, commercialization, process development and corporate governance at ImClone, InterMune and Medivation. J.D. Stanford.


Ronald Bracken
VP, Regulatory Affairs and Quality Assurance
USA

Accomplished Regulatory, Research and Development Executive with 24 years experience in corporate R&D and manufacturing environments in numerous medical fields.



Thomas Kelly
VP, Product Development
USA

Medical products executive with 30 years experience in management, R&D, marketing, QA/RA and manufacturing for medical devices and pharmaceuticals at Baxter, BD, Nikkiso & Dow.
Cornelia Durand-Mura
VP, Commercial Operations
Brazil

Experienced leader in the development and launch of innovative oncology products at Merck-Serono and Baxter. B.S. in Biomedicine studies and M.B.A in Marketing from Fundação Getulio Vargas, Brazil.
Amy Howard
VP, Marketing
USA

Marketing Operations leader with oncology launch and marketing experience at Biogen and Genentech. B.S. Union College; M.B.A. Boston College.


Jack Tuszynski, PhD
VP, Medical and Biophysics R&D
Canada

M.Sc., PhD and D.Sc. in Physics and Bioinformatics, Prof. and Experimental Oncology, Cross Cancer Institute, University of Alberta, Edmonton, Canada.




Antonio Iemma, PhD
VP, Mathematics and Statistics
Brazil

Master in Applied Statistics and PhD in Experimental Statistics from University of São Paulo, Brazil. Post-Doctorate in Statistical Analysis of Unbalanced Data at the University College of Gembloux, Belgium. Specialization in Design of Experiments (DOE) at the University of Marseille, France.
Lucas Batista Gabriel
Director, IT and SW Development
Brazil

Senior Software Engineer, expert in Software Development and AI. Computer Engineer and Computer Science from University of São Paulo, Brazil.

Jaap Laufer, MD PharmD
Director, European RA and QA
Netherlands

Specialized in implant, high risk device and combination product submissions, FDA QSR compliance and clinical study submissions and compliance. More than 30 years regulatory and clinical experience.
Pedro Strabelli
Senior Software Engineer
Brazil

Senior Software Engineer. Computer Engineer and Computer Science from University of São Paulo, Brazil


Alan Machado Coelho
Software Engineer
Brazil

Software Engineer. Electrical Engineer with Emphasis on Automation and Control from University of São Paulo, Brazil.



Tatiana Zanesco
Study Coordinator
Brazil

BS in Biomedicine. Study coordinator at Hospital Sírio Libanês. Performed the role of study coordinator of liver transplantation at Hospital das Clínicas (HC) of the University of São Paulo, Brazil.